BioNTech SE
BNTX
$105.07
-$5.81-5.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.76% | -786.05% | -171.78% | -117.67% | -112.20% |
| Total Depreciation and Amortization | 45.75% | 57.15% | 61.67% | 60.12% | 70.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -213.26% | -15.58% | 50.53% | 77.71% | 89.32% |
| Change in Net Operating Assets | -135.57% | -89.97% | -78.44% | -48.69% | -44.07% |
| Cash from Operations | -157.75% | -104.28% | -96.40% | -71.95% | -66.99% |
| Capital Expenditure | 24.21% | -4.31% | -14.56% | -2.83% | 9.40% |
| Sale of Property, Plant, and Equipment | 907.76% | -- | -- | 166.68% | -64.55% |
| Cash Acquisitions | 77.47% | 77.47% | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 132.28% | 122.38% | 71.51% | -33.84% | -98.27% |
| Cash from Investing | 124.69% | 116.70% | 69.82% | -21.51% | -98.32% |
| Total Debt Issued | -- | -- | -- | -33.33% | -50.00% |
| Total Debt Repaid | 19.27% | -33.42% | -13.61% | -36.46% | -38.26% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 99.90% | 73.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 88.05% | 89.67% | 94.12% | 93.78% | 68.26% |
| Foreign Exchange rate Adjustments | 106.83% | -137.46% | 215.44% | -725.33% | -112.75% |
| Miscellaneous Cash Flow Adjustments | -84.54% | -44.69% | -98.06% | 38,089.00% | 29,675.30% |
| Net Change in Cash | 96.61% | 137.21% | 11.32% | -5,620.30% | -183.48% |